| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0068 | 0.9 |